Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Aug 29;40(4):671–676. doi: 10.1007/s11596-020-2236-7

Targeted Antagonism of Vascular Endothelial Growth Factor Reduces Mortality of Mice with Acute Respiratory Distress Syndrome

Zhao Zhang 1, Dong-shi Lu 1, Dan-qing Zhang 1, Xin Wang 2, Yu Ming 3,, Zhou-yang Wu 1,
PMCID: PMC7456355  PMID: 32862377

Summary

Acute respiratory distress syndrome (ARDS) is associated with a mortality of 45%. Our previous research indicated that anti-vascular endothelial growth factor (VEGF) could maintain the normal structure and function of the respiratory barrier. However, systemic application of VEGF antagonists would lead to animal death. This study attempts to study the targeted drug delivery for ARDS. In this study, we used soluble fms-like tyrosine kinase-1 (sFlt)-targeted ultrasound microbubbles to antagonize the effect of VEGF on lung tissue. Ninety male BALB/c mice were randomly assigned to 6 groups: phosphate buffer saline (PBS) group (PBS+PBS); blank group (PBS+empty microbubbles); lipopolysaccharide (LPS) group (LPS+PBS); ARDS group (LPS+empty microbubbles); control group (PBS+sFlt microbubbles); and treatment group (LPS+sFlt microbubbles). After administration of LPS or PBS in the corresponding groups, the sFlt-targeted microbubbles or empty microbubbles were injected into the blood circulation. Then the lungs were irradiated with ultrasound, which ruptured the drug-loaded microbubbles and helped release drugs to the lung tissues targeted. The lung injury score, lung wet/dry ratio (W/D), liver and kidney functions, and the mortality of the mice in all groups were investigated at the predetermined time point. The difference in mortality between groups was examined by Fisher test. Other data were analyzed by one-way analysis of variance (ANOVA). A value of P<0.05 indicates that the difference was significant. The results showed that the PaO2 levels were normal in the PBS group, the blank group, and the control group. The LPS group and ARDS group showed significant hypoxia. PaO2 was improved significantly in the treatment group. The lung injury score and W/D were normal in the PBS group, the blank group, and the control group. The lung injury score and W/D increased significantly in the LPS group and ARDS group and decreased in the treatment group (P<0.05). The mortality rate of the ARDS model was 60% (95% confidence interval 47.5%–72.5%), and that with sFlt-targeted microbubbles was significantly lower at only 40% (95% confidence interval 27.5%–52.5%, P<0.05). It was concluded that anti-VEGF with sFlt targeted ultrasound microbubbles attenuated the lung injury and ultimately reduced the 7-day mortality effectively. It might be a suitable therapeutic tool for the treatment of ARDS.

Key words: acute respiratory distress syndrome, vascular endothelial growth factor, soluble fms-like tyrosine kinase-1, ultrasound microbubble, lipopolysaccharide

Conflict of Interest Statement

I declare on behalf of my co-authors and myself that we do not have any conflict of interest.

Footnotes

This study was supported by Scientific Research Fund of Hubei Provincial Department of Education (No. B2016081) and Young Scholar Research Grant of Chinese Anesthesiologist Association (No. 21700007).

Contributor Information

Zhao Zhang, Email: lyzzaaaa@126.com.

Yu Ming, Email: 497396197@qq.com.

Zhou-yang Wu, Email: wzy6638@hotmail.com.

References

  • 1.Beitler JR, Schoenfeld DA, Thompson BT. Preventing ARDS: progress, promise, and pitfalls. Chest. 2014;146(4):1102–1113. doi: 10.1378/chest.14-0555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zhang Z, Wu Z, Xu Y, et al. Vascular endothelial growth factor increased the permeability of respiratory barrier in acute respiratory distress syndrome model in mice. Biomed Pharmacother. 2019;109:2434–2440. doi: 10.1016/j.biopha.2018.11.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tao H, Li N, Zhang Z, et al. Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway. Shock. 2019;51(1):131–138. doi: 10.1097/SHK.0000000000001124. [DOI] [PubMed] [Google Scholar]
  • 4.Wewers TM, Mayer AB, Pfleiderer A, et al. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation. Kidney Int. 2019;95(5):1091–1102. doi: 10.1016/j.kint.2018.11.023. [DOI] [PubMed] [Google Scholar]
  • 5.Wallace K, Bean C, Bowles T, et al. Hypertension, Anxiety, and Blood-Brain Barrier Permeability Are Increased in Postpartum Severe Preeclampsia/Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome Rats. Hypertension. 2018;72(4):946–954. doi: 10.1161/HYPERTENSIONAHA.118.11770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Xing L, Shi Q, Zheng K, et al. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer. Theranostics. 2016;6(10):1573–1587. doi: 10.7150/thno.15164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chen Z, Xie M, Wang X, et al. Efficient gene delivery to myocardium with ultrasound targeted microbubble destruction and polyethylenimine. J Huazhong Univ Sci Technolog Med Sci. 2008;28(5):613–617. doi: 10.1007/s11596-008-0528-4. [DOI] [PubMed] [Google Scholar]
  • 8.Wu Z, Ming Y, Zhang Z, et al. Edaravone rescues the lung by inhibiting lipid peroxidation and pro-inflammatory cytokines in a rat model. Chin Med J (Engl) 2014;127(5):968–970. [PubMed] [Google Scholar]
  • 9.Zebrowski BK, Yano S, Liu W, et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res. 1999;5(11):3364–3368. [PubMed] [Google Scholar]
  • 10.Ibrahim KE, Al-Mutary MG, Bakhiet AO, et al. Histopathology of the Liver, Kidney, and Spleen of Mice Exposed to Gold Nanoparticles. Molecules. 2018;23(8):1848–1850. doi: 10.3390/molecules23081848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Franco RD. Mouse Models of Acute Lung Injury and ARDS. Methods Mol Biol. 2018;1809:341–350. doi: 10.1007/978-1-4939-8570-8_22. [DOI] [PubMed] [Google Scholar]
  • 12.Giacomo B, John GL, Tai P, et al. Epidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800. doi: 10.1001/jama.2016.0291. [DOI] [PubMed] [Google Scholar]
  • 13.Liao AH, Li YK, Lee WJ, et al. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging. Ultrasound Med Biol. 2012;38(11):1938–1948. doi: 10.1016/j.ultrasmedbio.2012.07.013. [DOI] [PubMed] [Google Scholar]
  • 14.Mahasreshti PJ, Kataram M, Wang MH, et al. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin Cancer Res. 2003;9(7):2701–2710. [PubMed] [Google Scholar]
  • 15.Leelahavanichkul A, Huang Y, Hu X, et al. Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1. Kidney Int. 2011;80(11):1198–1211. doi: 10.1038/ki.2011.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cockrell AS, Yount BL, Scobey T, et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol. 2016;2(2):16226–16230. doi: 10.1038/nmicrobiol.2016.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Smith BJ, Grant KA, Bates JH. Linking the development of ventilator-induced injury to mechanical function in the lung. Ann Biomed Eng. 2013;41(3):527–36. doi: 10.1007/s10439-012-0693-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gotts JE, Bernard O, Chun L, et al. Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice. Am J Physiol Lung Cell Mol Physiol. 2019;317(5):L717–L736. doi: 10.1152/ajplung.00132.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Current Medical Science are provided here courtesy of Nature Publishing Group

RESOURCES